D-0051-2015 Class III Terminated
FDA drug recall D-0051-2015 was initiated by Valeant Pharmaceuticals North America LLC on Jun 5, 2014 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Package Insert The recall status is terminated (terminated Jul 27, 2017). Affected quantity: 20,499 HDPE bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 5, 2014
- Initiation Date
- Jun 5, 2014
- Termination Date
- Jul 27, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 20,499 HDPE bottles
Product description
APLENZIN¿ (bupropion hydrobromide), extended-release tablets, 174 mg, 7-count HDPE bottle, Rx Only, Manufactured by Valeant Pharmaceuticals International, Inc. Steinbach MB, Canada R5G 1Z7, NDC 0024-5810-07.
Reason for recall
Labeling: Incorrect or Missing Package Insert
Distribution pattern
Nationwide
Code information
Lot # 13E019P; Exp 03/17
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0051-2015
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026